BPC-157, TB4, and KPV (60mg Blend)

BPC-157 20mg (Body Protection Compound-157) is a 15-amino acid peptide fragment originally isolated from mammalian gastric juice, investigated for its potential role in nitric oxide pathway modulation, growth factor signaling, and extracellular matrix remodeling. In cell studies, experimental research suggests that BPC 157 may support angiogenic responses and cytoprotective mechanisms under cellular stress conditions. Mechanistically, molecular analysis using Western blot techniques suggested increased phosphorylation of p21-activated kinase and paxillin following exposure to BPC 157, while total protein expression levels remained unchanged, implying it may support intracellular signaling through post-translational modification rather than protein synthesis. It’s also studied heavily for GI effects — BPC-157 research has extensively documented mucosal healing and cytoprotection.

TB4 20mg (Thymosin Beta-4) is a peptide that stimulates actin and angiogenesis to promote faster structural recovery. Functionally, it promotes new blood vessel formation and improves oxygen delivery to damaged tissues. Its main proposed mechanism relates to actin regulation, promoting cell migration into injured tissue.

KPV 20mg is a naturally derived tripeptide corresponding to positions 11 to 13 of alpha-melanocyte-stimulating hormone (alpha-MSH), retaining the potent anti-inflammatory activity of its parent hormone while lacking alpha-MSH’s pigmentation effects. Its primary studied mechanism is that it inhibits nuclear factor-kappa B (NF-kB), a transcription factor that controls the transcription of hundreds of inflammatory genes, including pro-inflammatory cytokines such as TNF-alpha, IL-1beta, and IL-6, as well as chemokines, adhesion molecules, and COX-2. Interestingly, research indicates KPV is unlikely to mediate its effects through melanocortin receptors but is more likely to act through inhibition of IL-1beta functions, distinguishing it mechanistically from full-length alpha-MSH. It also has decent oral stability: KPV maintains oral bioavailability and has shown efficacy in colitis models when taken by mouth, a rare property for peptides that are typically destroyed in the digestive tract.

For laboratory research use only. Not intended for human or animal consumption, diagnostic, or therapeutic use. Not a drug, dietary supplement, or cosmetic.